-
EP2623113
European procedure
Extract from the Register of European Patents
EP About this file: EP2623113
| EP2623113 - Compound for enzyme inhibition [Right-click to bookmark this link] | |||
| Former [2013/35] | Compounds for enzyme inhibition | ||
| [2017/01] | Status | No opposition filed within time limit Status updated on 06.04.2018 Database last updated on 12.07.2024 | |
| Former | The patent has been granted Status updated on 28.04.2017 | ||
| Former | Grant of patent is intended Status updated on 20.12.2016 | ||
| Former | Examination is in progress Status updated on 11.11.2016 | Most recent event Tooltip | 06.04.2018 | No opposition filed within time limit | published on 09.05.2018 [2018/19] | Applicant(s) | For all designated states Onyx Therapeutics, Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US | [2017/38] |
| Former [2013/32] | For all designated states Onyx Therapeutics, Inc. 249 East Grand Avenue South San Francisco, CA 94080 / US | Inventor(s) | 01 /
Zhou, Han-Jie 830 Argus Court Foster City, CA 94404 / US | 02 /
Sun, Congcong M. 18785 Tilson Avenue Cupertino, CA 95014 / US | 03 /
Shenk, Kevin D. 565 Arastradero Road, 203 Palo Alto, CA 94306 / US | 04 /
Laidig, Guy J. 329 Waverley Street Menlo Park, CA 94025 / US | [2017/22] |
| Former [2013/32] | 01 /
Zhou, Han-jie 830 Argus Court Foster City, CA 94404 / US | ||
| 02 /
Sun, Congcong, M. 18785 Tilson Avenue Cupertino, CA 95014 / US | |||
| 03 /
Shenk, Kevin, D. 565 Arastradero Road, 203 Palo Alto, CA 94306 / US | |||
| 04 /
Laidig, Guy, J. 329 Waverley Street Menlo Park, CA 94025 / US | Representative(s) | Carlisle, Julie Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [2017/22] |
| Former [2013/32] | Carlisle, Julie Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 13157801.5 | 09.11.2006 | [2013/32] | Priority number, date | US20050736118P | 09.11.2005 Original published format: US 736118 P | US20060842582P | 05.09.2006 Original published format: US 842582 P | [2013/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2623113 | Date: | 07.08.2013 | Language: | EN | [2013/32] | Type: | A3 Search report | No.: | EP2623113 | Date: | 16.04.2014 | Language: | EN | [2014/16] | Type: | B1 Patent specification | No.: | EP2623113 | Date: | 31.05.2017 | Language: | EN | [2017/22] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.03.2014 | Classification | IPC: | C07K5/062, A61K38/55, C07K5/08, C07K5/10, C07K5/065, C07K5/078, C07K5/083, C07K5/087, C07K5/097, C07K5/117 | [2014/16] | CPC: |
A61K31/69 (EP,US);
C07K5/06 (KR);
C07K5/08 (US);
A61K38/06 (US);
A61K38/55 (EP,KR,US);
A61K45/06 (EP,US);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
C07K5/06026 (EP,US);
C07K5/06034 (EP,US);
C07K5/0606 (EP,US);
C07K5/06078 (EP,US);
C07K5/06139 (EP,US);
C07K5/0806 (EP,US);
C07K5/0808 (EP,US);
C07K5/081 (EP,US);
C07K5/0812 (EP,US);
C07K5/0821 (EP,US);
| C-Set: |
A61K38/06, A61K2300/00 (EP,US)
|
| Former IPC [2013/32] | A61K38/55, C07K5/06, C07K5/08, C07K5/10 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2017/22] |
| Former [2013/32] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Verbindung zur Enzymhemmung | [2017/01] | English: | Compound for enzyme inhibition | [2017/01] | French: | Composé pour l'inhibition d'enzymes | [2017/01] |
| Former [2013/32] | Verbindungen zur Enzymhemmung | ||
| Former [2013/35] | Compounds for enzyme inhibition | ||
| Former [2013/32] | Composés pour l'inhibition d'enzymes | Examination procedure | 15.10.2014 | Examination requested [2014/48] | 24.11.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 29.01.2015 | Amendment by applicant (claims and/or description) | 09.05.2016 | Despatch of a communication from the examining division (Time limit: M06) | 10.11.2016 | Reply to a communication from the examining division | 21.12.2016 | Communication of intention to grant the patent | 20.04.2017 | Fee for grant paid | 20.04.2017 | Fee for publishing/printing paid | 20.04.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP06837164.0 / EP1948678 | Opposition(s) | 01.03.2018 | No opposition filed within time limit [2018/19] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 29.01.2015 | Request for further processing filed | 29.01.2015 | Full payment received (date of receipt of payment) Request granted | 11.02.2015 | Decision despatched | Fees paid | Renewal fee | 21.03.2013 | Renewal fee patent year 03 | 21.03.2013 | Renewal fee patent year 04 | 21.03.2013 | Renewal fee patent year 05 | 21.03.2013 | Renewal fee patent year 06 | 21.03.2013 | Renewal fee patent year 07 | 27.11.2013 | Renewal fee patent year 08 | 10.11.2014 | Renewal fee patent year 09 | 25.11.2015 | Renewal fee patent year 10 | 10.11.2016 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US6831099 (CREWS CRAIG M [US], et al) [A] 1-36* the whole document *; | [E]EP2564834 (ONYX THERAPEUTICS INC [US]) [E] 1-4,6,8-10,12-19,21,22,25,26,28,29,31,32 * paragraphs [0066] - [0085] * * paragraph [0091] * * paragraph [0132] * * paragraph [0139]; claims 8, 11, 14 * * paragraph [0009] * * paragraph [0145] *; | [Y] - MYUNG, JAYHYUK ET AL, "Lack of proteasome active site allostery as revealed by subunit-specific inhibitors", MOLECULAR CELL, (2001), vol. 7, no. 2, pages 411 - 420, XP002342741 [Y] 1,4,8-10 * compound 7 * DOI: http://dx.doi.org/10.1016/S1097-2765(01)00188-5 | [Y] - ELOFSSON M ET AL, "TOWARDS SUBUNIT-SPECIFIC PROTEASOME INHIBITORS: SYNTHESIS AND EVALUATION OF PEPTIDE ALPHA',BETA'-EPOXYKETONES", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, (1995), vol. 6, no. 11, ISSN 1074-5521, pages 811 - 822, XP001002198 [Y] 1,4,8-10 * page 819, column 2 - page 820, column 1; compound 16 * DOI: http://dx.doi.org/10.1016/S1074-5521(99)80128-8 |